Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Tuesday, April 2, 2019 - 02:10 in Health & Medicine

Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net